Phacilitate Leaders Forum

Phacilitate Leaders Europe Agenda 2018


Part 1: Combining the expertise of clinical centres of excellence and the ATMP industry for future clinical success in Europe

Shared workshops
  • What can we learn from current partnership models between the cell and gene therapy industry and centres of excellence in Europe?
  • Partnership challenges: how do you align your expectations to create a successful collaboration?
  • How are EU centres of excellence aligning their GMP requirements to match that of the manufacturers- are both sides on the same page with GMP?
Diego Ardigo, Head R&D Rare Diseases Unit Head - Chiesi Farmaceutici SpA
Marc Turner, Medical Director - Scottish National Blood Transfusion Service
Michela Gabaldo, Head, Alliance Management & Regulatory Affairs - San Raffaele-Telethon Institute for Gene Therapy
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd